Over the years, with the development of DNA sequencing technologies, an increasing number of cases with INAD and pathogenic variants in PLA2G6 have been identified effectively, allowing for efficient genetic confirmation of the diagnosis. This evidence concerns the gene PLA2G6 and neurodegeneration with brain iron accumulation 2A.